Product NDC: | 0781-3009 |
Proprietary Name: | Anectine |
Non Proprietary Name: | Succinylcholine Chloride |
Active Ingredient(s): | 20 mg/mL & nbsp; Succinylcholine Chloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-3009 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA008453 |
Marketing Category: | NDA |
Start Marketing Date: | 19520820 |
Package NDC: | 0781-3009-95 |
Package Description: | 10 VIAL, MULTI-DOSE in 1 CARTON (0781-3009-95) > 10 mL in 1 VIAL, MULTI-DOSE (0781-3009-70) |
NDC Code | 0781-3009-95 |
Proprietary Name | Anectine |
Package Description | 10 VIAL, MULTI-DOSE in 1 CARTON (0781-3009-95) > 10 mL in 1 VIAL, MULTI-DOSE (0781-3009-70) |
Product NDC | 0781-3009 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Succinylcholine Chloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; PARENTERAL |
Start Marketing Date | 19520820 |
Marketing Category Name | NDA |
Labeler Name | Sandoz Inc |
Substance Name | SUCCINYLCHOLINE CHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Depolarizing Neuromuscular Blocker [EPC],Neuromuscular Depolarizing Blockade [PE] |